Page last updated: 2024-09-02

1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane and Carcinoma, Squamous Cell

1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane has been researched along with Carcinoma, Squamous Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bao, A; Cheng, Z; Cutler, CS; Hoppmann, S; Jiang, H; Liu, H; Miao, Z; Qi, S1

Other Studies

1 other study(ies) available for 1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane and Carcinoma, Squamous Cell

ArticleYear
177Lu-DO3A-HSA-Z EGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas.
    Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2012, Volume: 17, Issue:5

    Topics: Amino Acid Sequence; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Copper; ErbB Receptors; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Mice; Mice, Nude; Models, Molecular; Molecular Sequence Data; Peptides; Positron-Emission Tomography; Radiopharmaceuticals; Serum Albumin; Squamous Cell Carcinoma of Head and Neck; Tissue Distribution; Tomography, Emission-Computed, Single-Photon

2012